JP2002528085A5 - - Google Patents

Download PDF

Info

Publication number
JP2002528085A5
JP2002528085A5 JP2000578465A JP2000578465A JP2002528085A5 JP 2002528085 A5 JP2002528085 A5 JP 2002528085A5 JP 2000578465 A JP2000578465 A JP 2000578465A JP 2000578465 A JP2000578465 A JP 2000578465A JP 2002528085 A5 JP2002528085 A5 JP 2002528085A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000578465A
Other languages
Japanese (ja)
Other versions
JP3910798B2 (ja
JP2002528085A (ja
Filing date
Publication date
Priority claimed from US09/178,115 external-priority patent/US6297041B1/en
Priority claimed from US09/177,776 external-priority patent/US6297051B1/en
Application filed filed Critical
Priority claimed from PCT/US1999/024879 external-priority patent/WO2000024913A2/en
Publication of JP2002528085A publication Critical patent/JP2002528085A/ja
Publication of JP2002528085A5 publication Critical patent/JP2002528085A5/ja
Application granted granted Critical
Publication of JP3910798B2 publication Critical patent/JP3910798B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000578465A 1998-10-23 1999-10-22 Mn遺伝子およびタンパク質 Expired - Fee Related JP3910798B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/177,776 1998-10-23
US09/178,115 1998-10-23
US09/178,115 US6297041B1 (en) 1992-03-11 1998-10-23 MN gene and protein
US09/177,776 US6297051B1 (en) 1997-01-24 1998-10-23 MN gene and protein
PCT/US1999/024879 WO2000024913A2 (en) 1998-10-23 1999-10-22 Mn gene and protein

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006318591A Division JP4044597B2 (ja) 1998-10-23 2006-11-27 Mn遺伝子およびタンパク質

Publications (3)

Publication Number Publication Date
JP2002528085A JP2002528085A (ja) 2002-09-03
JP2002528085A5 true JP2002528085A5 (https=) 2005-07-07
JP3910798B2 JP3910798B2 (ja) 2007-04-25

Family

ID=26873634

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000578465A Expired - Fee Related JP3910798B2 (ja) 1998-10-23 1999-10-22 Mn遺伝子およびタンパク質
JP2006318591A Expired - Lifetime JP4044597B2 (ja) 1998-10-23 2006-11-27 Mn遺伝子およびタンパク質
JP2007233872A Expired - Fee Related JP4488373B2 (ja) 1998-10-23 2007-09-10 Mn遺伝子およびタンパク質

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2006318591A Expired - Lifetime JP4044597B2 (ja) 1998-10-23 2006-11-27 Mn遺伝子およびタンパク質
JP2007233872A Expired - Fee Related JP4488373B2 (ja) 1998-10-23 2007-09-10 Mn遺伝子およびタンパク質

Country Status (11)

Country Link
EP (2) EP1832653A1 (https=)
JP (3) JP3910798B2 (https=)
AT (1) ATE376056T1 (https=)
AU (1) AU758957C (https=)
CA (1) CA2347649C (https=)
CY (1) CY1107268T1 (https=)
DE (1) DE69937364T2 (https=)
DK (1) DK1123387T3 (https=)
ES (1) ES2296412T3 (https=)
NO (1) NO328884B1 (https=)
WO (1) WO2000024913A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
US20040077081A1 (en) 2001-02-07 2004-04-22 Egbert Oosterwijk Hybridoma cell line g250 and its use for producing monoclonal antibodies
AR036833A1 (es) * 2001-10-18 2004-10-06 Bayer Corp Anticuerpos humanos que se unen a mn y tienen actividad neutralizante de la adhesion celular.
US7910549B2 (en) * 2001-12-13 2011-03-22 Institute Of Virology Of The Slovak Academy Of Sciences MN gene and protein
EP2508596B1 (en) 2002-02-21 2015-08-12 Institute Of Virology MN/CA IX-specific monoclonal antibodies generated from MN/CA IX-deficient mice and methods of use
DK3031910T3 (en) 2002-02-21 2017-10-23 Inst Virology MN / CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED BY MN / CA IX-DEFICIENT MOUSE AND METHODS OF USE
AU2003223186A1 (en) * 2002-05-23 2004-01-23 Bayer Healthcare SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2
US7632496B2 (en) 2002-07-01 2009-12-15 Wilex Ag Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas
EP1576010A4 (en) * 2002-08-23 2006-12-27 Chiron Corp THERAPEUTIC COMPOSITIONS AND METHODS FOR CANCER CHARACTERIZED BY EXPRESSION OF MN / CA IX ANTIGEN ASSOCIATED WITH TUMORS
CA2691447A1 (en) 2002-11-26 2004-06-10 Institute Of Virology Ca ix-specific inhibitors
EP1673630A4 (en) * 2003-10-16 2009-04-29 Inst Virology MN / CA IX AND CANCER PROGNOSIS
AU2005241093B2 (en) 2004-05-04 2008-06-05 Institute Of Virology Of Slovak Academy Of Sciences MN/CA IX/ CA9 and renal cancer prognosis
US7820159B2 (en) 2006-10-31 2010-10-26 Instiute of Virology of the Slovak Academy of Sciences MN/CA IX and EGFR pathway inhibition
US8399624B1 (en) * 2009-06-25 2013-03-19 Esbatech, An Alcon Biomedical Research Unit Llc Acceptor framework for CDR grafting
CA2901531C (en) 2013-02-22 2022-03-29 Wilex Ag Caix stratification based cancer treatment
CZ2014527A3 (cs) * 2014-08-05 2016-02-17 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Způsob detekce aktivní formy analytů ve vzorku a stanovení schopnosti dalších látek vázat se do aktivních míst těchto analytů

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192678C (en) * 1994-06-15 2010-12-14 Jan Zavada Mn gene and protein
US6329501B1 (en) * 1997-05-29 2001-12-11 Auburn University Methods and compositions for targeting compounds to muscle
WO1999058561A1 (fr) * 1998-05-14 1999-11-18 Pasteur Merieux Serums & Vaccins Mimotopes du virus de l'hepatite c

Similar Documents

Publication Publication Date Title
BE2018C020I2 (https=)
BE1025464I2 (https=)
BE2008C046I2 (https=)
BRPI0017527B8 (https=)
BE2008C047I2 (https=)
BRPI0001672A2 (https=)
JP2002513110A5 (https=)
BRPI0001542A2 (https=)
JP2002531906A5 (https=)
JP2002527957A5 (https=)
JP2002506970A5 (https=)
JP2002528085A5 (https=)
JP2002516230A5 (https=)
BRPI0012675B8 (https=)
BRPI0017522A2 (https=)
IN191492B (https=)
BRMU7902607U2 (https=)
BRPI0303609A (https=)
BRPI9917761A2 (https=)
ECSMU990149U (https=)
FR2765127A3 (https=)
FR2769188A3 (https=)
GB9923411D0 (https=)
CN3098238S (https=)
CN3097442S (https=)